Great opportunity to get some excellent clinical research training across the spectrum of experimental medicine trials but also to work up own projects, encouraged to do masters/MD or further. Specialty agnostic. DM me if interested jobs.nhs.uk/candidate/joba…

Delighted to announce that the Protocol for the @ @Petneck2 trial is now published in BMC Cancer BMC Series. The trial is open across 31 sites and has recruited 293 patients! Paul Nankivell, Hisham Mehanna, Birmingham Cancer Research UK Clinical Trials Unit rdcu.be/dNoK3

Can liquid biopsies detect methylomic intratumoural heterogenity in HNSCC? Could cfDNA methylation be used as a tool for ITH assessment and serial sampling? Cancer and Genomic Sciences Karl Payne Deena M.A. Gendoo InHANSE RESEARCH @OncologyAdvance authors.elsevier.com/sd/article/S13…

Congratulations to the Freeman Hospital team for randomising the 300th patients in the PETNECK 2 trial. 349 patients have registered to the study. A massive thanks to all our NHS staff and patients for their ongoing support.

Thanks for the invitation to speak. It was a great event!

Come join a great academic training scheme Birmingham Acute Care Research Centre UoB School of Infection, Inflammation & Immunology College of Medicine and Health (UoB) ACFs open - Intensive care medicine, Anaesthesia, Acute Medicine and Respiratory medicine! DM me for more info FICMNews British Thoracic Society (BTS) TRIC Network INSPIREresp SAM Online

Delighted also to present the ongoing young-investigators-led Head and Neck Cancer International Group & IFHNOS carcinoma of unknown primary programme led by Paul Nankivell, A. Williamson, Vin Paleri, C. Holsinger Dr. Chris Holsinger & Hisham Mehanna, et al. #HNCIG_meeting_Athens

📢 Calling all clinicians interested in pursuing research! BHP's clinical-academic training programmes are now open for applications, with pathways suitable for varying career stages. 🧵 Read on for more about our programmes...

Our latest scheme is the BHP New Consultant Fellowship, designed for qualified medical staff who have taken up their first consultant position in the past 18 months but don't have time allocated within their job plans for research. Learn more and apply > birminghamhealthpartners.co.uk/training/new-c…

Fantastic - well done James

JOB ALERT - exciting opportunity and a pivotal time to drive RDI at our large multi-site NHS Trust - integrate with the regional health research ecosystem for the benefit of our patients (and get to work closely with me and the exec team) jobs.nhs.uk/candidate/joba…

Fear of Cancer Recurrence and Fear of Cancer Progression, Digital Resource Engagement and Health Literacy: A Review mdpi.com/3066468 #mdpicurroncol via Current Oncology PETNECK 2 Paul Nankivell very proud of Maebh who took the lead in this paper!

New MRes in Neurogenetics open for applications now. ⁦⁦Daniel Fulton⁩ ⁦College of Medicine and Health (UoB)⁩ ⁦Uni of Birmingham⁩ ⁦UoB Neuroscience and Ophthalmology⁩ #neurogenetics

Our recent publications from the @PETNeck2 programme spotlight critical gaps in predictive modelling for Head & Neck cancers, marked by high bias and underwhelming performance. Surprisingly, ML/AI remains vastly underutilized in this space! Links below👇Paul Nankivell Hisham Mehanna

National Institute for Health and Care Research InHANSE RESEARCH @Janine_dretzke #Oncology #Prediction bmjopen.bmj.com/content/14/12/… frontiersin.org/journals/oncol…

Starting 2025 with good news! We have randomised our 400th patient. Congratulations to Richard Williams and the team at Derriford Hospital. 452 patients are now registered into PETNECK 2 trial so a big thank you to all our recruiting sites! Please keep your efforts going.